Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Zhongbao Pharmaceutical Co., Ltd. is a specialized Chinese pharmaceutical manufacturer based in Tianjin, primarily focused on the development and production of chemical drug formulations. As a key subsidiary of the publicly traded Tianjin Lisheng Pharmaceutical, the company operates modern GMP-certified facilities specializing in sterile injections and solid oral dosage forms. Their core therapeutic focus includes cardiovascular medicine, anti-infectives, and central nervous system treatments. Notable products in their commercial portfolio include Alprostadil for injection and Nitroglycerin, which are widely utilized in clinical settings across China. The company leverages its integration within the broader Tianjin Pharmaceutical Group to maintain a significant presence in the domestic healthcare supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Zhongbao Pharmaceutical.